摘要
目的探讨呼出气一氧化氮(FeNO)在咳嗽变异型哮喘(CVA)和支气管哮喘(哮喘)之间的差异。方法选取我院2015年6月—2016年9月呼吸科门诊就诊的CVA患者47例及哮喘患者80例作为研究对象,进行呼出气一氧化氮检测,并进行统计分析。结果 CVA患者FeNO值为44(25)ppb,哮喘患者FeNO值为50(26)ppb,哮喘患者FeNO值高于CVA患者,两者差异有统计学意义(P<0.05)。CVA患者和哮喘患者的FeNO值均高于正常参考值,且哮喘患者FeNO值高于CVA患者。结论 FeNO检测可作为无创方法评估CVA和哮喘患者的气道炎症水平,对二者的诊断和治疗具有一定的指导意义。
Objective To investigate the differences of fractional exhaled nitric oxide （FeNO） between CVA and asthma. Methods From June 2015 to September 2016, 47 patients with CVA and 80 cases with asthma in outpatient department of respiration as research object in our hospital, which were exhaled nitric oxide detection, and took statistical analysis. Results The FeNO value of CVA was 44（25）ppb in CVA patients, and the FeNO value was 50（26） ppb in asthma patients, and the FeNO value of asthma was higher than that of CVA, the difference was statistically significant （P 〈 0.05）. CVA and asthma patients＇FeNO values were higher than the normal reference value, and the FeNO value of asthma patients were higher than that of CVA patients. Conclusion FeNO can be used as noninvasive method to evaluate the level of airway inflammation in CVA were higher than asthma patients, and it has some guiding significance for the diagnosis and treatment of the two groups.
出处
《中国卫生标准管理》
2017年第7期26-28,共3页
China Health Standard Management
基金
2016年福建中医药大学校管科研课题(XB2016055)
